Market Chatter: GE Healthcare to Acquire Sofie Biosciences in $945 Million Cash Deal

MT Newswires Live10-05 19:54

GE HealthCare Technologies (GEHC) is expected to announce its acquisition of Sofie Biosciences, a manufacturer of radioactive substances used in medical-imaging procedures, for $945 million in cash, The Wall Street Journal reported Monday, citing the company.

The medical-equipment maker will buy Sofie from private equity firm Trilantic North America, with the deal likely to be announced Monday, according to the report.

GE HealthCare didn't immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment